NBM
NBM is a privately held company offering SurfLink, a revolutionary permanent bio-mimicking surface treatment.
NBM
Industry:
Medical Device
Address:
Gland, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.nbmolecules.com
Status:
Active
Contact:
+41 22 354 00 54
Email Addresses:
[email protected]
Official Site Inspections
http://www.nbmolecules.com
- Host name: megaphone-s7.megaphone.ch
- IP address: 212.74.179.245
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich

More informations about "NBM"
NBMolecules
Downloads The SurfLink ® surface treatment consists of a layer of phosphorous-rich molecules, which is applied to the titanium implant surface. The treated surface mimics the natural, biological environment, thus promoting cell and โฆSee details»
Nano Bridging Molecules SA - BioAlps
Organization Type . Private Company. Visit website Domains. Musculoskeletal & Inflammation ... [email protected] . BioAlps Association. Avenue de Sécheron 15 1202 Geneva, โฆSee details»
NBMolecules history and development of Surflink® technology
NBMolecules SurfLink technology is protected by patents owned by the UniGe and EPFL. According to a license agreement entered into with UniGe and EPFL, the university spin-off โฆSee details»
NBMolecules team, directors and scientific advisory
Revolutionary surface treatment for bone anchored implants Menu. Surflink ®. Technology; Characteristics; Pre-clinical results; Clinical results; Products; CompanySee details»
Nano Bridging Molecules - Crunchbase Company Profile & Funding
Nano Bridging Molecules. Nano Bridging Molecules® SurfLink® technology has been developed over a period of 12 years by a multidisciplinary team from a number of renowned academic โฆSee details»
Nano Bridging Molecules SA (NBM) | LinkedIn
Nano Bridging Molecules SA (NBM) is a privately held Swiss company founded in 2002, is dedicated to developing and commercialising advanced bio-mimicking surface treatments for โฆSee details»
NBMolecules (fka suriasis) - VentureRadar
Suriasis Switzerland Private Nano Bridging Molecules (NBMolecules®), is a privately held Swiss Medical Device/Life Science Research and Development company, focusing on the โฆSee details»
Nano Bridging Molecules SA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Nano Bridging Molecules SA of Gland, VAUD. Get the latest business insights from Dun & Bradstreet.See details»
Nano Bridging Molecules - Overview, News & Competitors
NBMolecules®, a privately held Swiss Medical Device company founded in 2002, is dedicated to developing and licensing out advanced surface treatments for bone anchored implants. โฆSee details»
Nano Bridging Molecules SA โ Swiss Biotech
Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members, the association works to secure favorable framework โฆSee details»
Nano Bridging Molecules SA Receives CE Marking Certification for โฆ
P. 2 incorporated in 2002. In 2008 it established new laboratories and offices in Canton Vaud, Switzerland. It currently employs 7 people and has entered intoSee details»
Suriasis - VentureRadar
NBMolecules (fka suriasis) Switzerland Private Nano Bridging Molecules (NBMolecules®), is a privately held Swiss Medical Device/Life Science Research and Development company, โฆSee details»
Nano Bridging Molecules SA - startup.ch
Nano Bridging Molecules SA : The SurfLinkโข surface treatment by NBMolecules consists of a permanently bound layer of hydrophilic phosphorous-rich molecules, which is applied to the โฆSee details»
Nextsource | Company Profile | Nano Bridging Molecules
Explore the company profile of Nano Bridging Molecules (nbmolecules.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Nano Bridging Molecules SA - Drug pipelines, Patents, Clinical โฆ
Explore Nano Bridging Molecules SA with its drug pipeline, therapeutic area, technology platform, 2 literature.See details»
www.nbmolecules.com
%PDF-1.5 %âãÏÓ 232 0 obj > endobj 266 0 obj >/Filter/FlateDecode/ID[3B9EE2ADB92F4784B06B9B2FB68A3EE7>]/Index[232 86]/Info 231 โฆSee details»
NBMolecules products, unique clinical advantage for implant โฆ
Products NBMolecules ® offers SurfLink ®, a surface treatment for bone anchored implants.Through its bio-mimicking bone-like characteristics, SurfLink ® promotes โฆSee details»
New Bottle Co
Design. Performance. Crafted for durability and versatility, our bottles are available in a range of sizes (50ml โ 3L), shapes, and colors, offering the perfect canvas for your brand.See details»
NBMolecules' SurfLink® product clinical results
Clinical outcome. SurfLink โข may significantly improve bone regeneration and fixation resulting in clear Clinical Benefits โ When It Matters Mostโข NBM conducted 2 split-mouth prospective โฆSee details»
NBMolecules press releases
License Agreement MIS & NBM 2015.07,27; EDI Product News - Nano Bridging Molecules SurfLink Dental: EDI 1/2014; Promising dental implant technology - NBMolecules receives โฆSee details»